Quest
Diagnostics

QUEST DIAGNOSTICS INCORPORATED
CLIENT SERVICE:

SPECIMEN INFORMATION
SPECIMEN: K4671284
REQUISITION:

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>11:50</th></tr><tr><td>RECEIVED:</td><td>03/03/2010</td><td>21:07</td></tr><tr><td>REPORTED:</td><td>03/09/2010</td><td>17:30</td></tr></table>

PATIENT INFORMATION
EPSTEIN,JEFFREY

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

PHONE: ████████████

REPORT STATUS PARTIAL
REPRINT
ORDERING PHYSICIAN

CLIENT INFORMATION
T11886 10013650
WOODSON MERRELL. M.D.
44 E 67TH STREET
NEW YORK, NY 10065

<table><tr><th colspan="6">The original copy of this report was printed on: 03/09/2010 at 08:16
Patient results contained in a facsimile or electronic
medical report are provided only upon the request of the
physician or authorized person. Facsimile or electronic
medical reports that are created before the final results
are reported are considered to be INTERIM RESULTS ONLY and
are subject to change by the laboratory.</th></tr><tr><td>Test Name</td><td></td><td>In Range</td><td>Out of Range</td><td>Reference Range</td><td>Lab</td></tr><tr><td>IGF-1</td><td></td><td>151</td><td></td><td>87-225 ng/mL</td><td>TBR</td></tr><tr><td>FSH</td><td></td><td>3.7</td><td></td><td>1.6-8.0 MIU/mL</td><td>TBR</td></tr><tr><td>LH</td><td></td><td>4.1</td><td></td><td>1.5-9.3 mIU/mL</td><td>TBR</td></tr><tr><td>PROLACTIN</td><td></td><td>2.6</td><td></td><td>2.0-18.0 ng/mL</td><td>TBR</td></tr><tr><td>PROGESTERONE</td><td></td><td>1.1</td><td></td><td>&lt;1.4 ng/mL</td><td>TBR</td></tr><tr><td>DHEA SULFATE</td><td></td><td>182</td><td></td><td>25-240 mcg/dL</td><td>TBR</td></tr><tr><td>TESTOSTERON, FR/TOT, LCMSMS
TESTOSTERONE, TOTAL</td><td></td><td></td><td>188 L</td><td>250-1100 ng/dL.</td><td>QNI</td></tr><tr><td colspan="5">Total Testosterone was measured by LCMSMS. The LCMSMS method
correlates well with our extraction/RIA method.</td><td></td></tr><tr><td>% FREE TESTOSTERONE
TESTOSTERONE, FREE</td><td></td><td>1.94
56.5</td><td></td><td>1.5-2.2 %
35.0-155.0 pg/mL</td><td></td></tr><tr><td>MTHFR,DNA MUTATION,NY</td><td></td><td></td><td>see note A</td><td></td><td>AMD</td></tr><tr><td>RESULT: POSITIVE FOR TWO
MUTATION</td><td>COPIES</td><td>OF THE C677T</td><td></td><td></td><td></td></tr><tr><td>DNA testing indicates
homozygous for the C677T
have the A1298C mutation.
with an increased risk
and vascular diseases.
and DNA testing for</td><td>this
mutation
This
for
Consider
at-risk</td><td>individual is
and does
has been
hyperhonocysteinemia
genetic
members.</td><td>not
associated

counseling</td><td></td><td></td></tr></table>

## EPSTEIN,JEFFREY - K4671284

Page 1 - Continued on Page 2

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated. All rights reserved. DN-RPAPR. 7/81

11-12
03/05/18 17:38 815262866 2/3

## EPSTEIN,JEFFREY - K4671284 (cont.)

Quest
Diagnostics

# PATIENT INFORMATION
EPSTEIN, JEFFREY

REPORT STATUS PARTIAL
REPRINT
ORDERING PHYSICIAN

QUEST DIAGNOSTICS INCORPORATED

<table><tr><th>SPECIMEN</th><th>INFORMATION</th><th></th></tr><tr><td>SPECIMEN:</td><td>X4671284</td><td></td></tr><tr><td>COLLECTED:</td><td>03/03/2010</td><td>11:50 </td></tr><tr><td>REPORTED:</td><td>03/09/2010</td><td>17:30 </td></tr></table>

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

CLIENT INFORMATION
T11886 10013650

Test Name In Range Out of Range Reference Range Lab

Laboratory testing supervised and results
monitored by U.N. Pratt, Ph.D.. FACMG,
Director, Molecular Genetics.

Hyperhomocysteinemia is a risk factor for arterial disease and venous thrombosis. Homocysteine levels are affected by nutritional and genetic factors. Since MINER is involved in methylation of homocysteine to methionine, individuals with MTHFR gene mutations that reduce enzyme activity may develop hyperhoncysteinenia and thus be at risk for vascular disease.

The C677T and A1298C mutations are detected by allele-specific signal amplification hybridizations of the and MTHFR chemi luminescent gene by detection of hybridized probes. Since genetic variation and other factors can affect the accuracy of direct mutation testing, these results should be interpreted in light of clinical and familial data.

This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Chantilly, UA. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.

ESTRAD|OL,ULTRASEN,LCMSMS

PENDING

PERFORMING LABORATORY INFORMATION:

PERFORMING LABORATORY INFORMATION:
AMD Quest Diagnostics Nichols Chantilly 14225 Newbrook Drive Chantilly VA 20151
Laboratory Director: Kenneth Sisco, MD,PhD CLIA No: 49D0221801
QNI Quest Diagnostics, Nichols Institute 33608 Ortega Highway San Juan Capistrano CA 92690
Laboratory Director: Dr. Jon M. Nakamoto CLIA No: 05D0643352
TBR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608
Laboratory Director: William E. Tarr, M.D. CLIA No: 31D0696246

EPSTEIN,JEFFREY - K4671284
Page 2 - End of Report

03/09/10 17:30 MJS262066 3/3

# PATIENT INFORMATION
EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

QUEST DIAGNOSTICS INCORPORATED
CLIENT SERVICE

SPECIMEN INFORMATION
SPECIMEN: X4666434
REQUISITION:

# PATIENT INFORMATION
ESPSTEIN,JEFFREY

DOB: 01/28/1953 AGE: 57
GENDER: M FASTING:

PHONE: ██████████

REPORT STATUS FINAL
REPRINT
ORDERING PHYSICIAN

CLIENT INFORMATION
111886 10013650
WOODSON MERRELL. M.D.
44 E 67TH STREET
NEW YORK. NY 10065

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>08:20</th></tr><tr><td>RECEIVED:</td><td>03/03/2010</td><td>20:43</td></tr><tr><td>REPORTED:</td><td>03/08/2010</td><td>08:32</td></tr></table>

The original copy of this report was printed on: 03/05/2010 at 08:16

Test Name: LEAD, BLOOD
In Range: <3
Out of Range: <empty>
Reference Range: <10 mcg/dL
Lab: TBR

Blood lead levels in the range of 5-9 mcg/dL have been
associated with adverse health effects in children aged
6 years and younger.

Industrial Exposure: <40 mcg/dL
mcg/dL = mcg/100g for OSHA
(refer to current governmental regulations for exposure
criteria)

Test Name: MERCURY, BLOOD
In Range: 5
Out of Range: <empty>
Reference Range: <=10 mcg/L
Lab: AMD

Test Name: ARSENIC, BLOOD
In Range: 4
Out of Range: <empty>
Reference Range: <23 mcg/L
Lab: AMD

Urine is usually the best specimen for the analysis
of Arsenic in body fluids. Blood levels tend to be
low even when urine concentrations are high.

PERFORMING LABORATORY INFORMATION:
AMD Quest Diagnostics Nichols Chantilly 14225 Newbrook Drive Chantilly VA 20151
Laboratory Director: Kenneth Sisco, MD,PhD CLIA No: 49D0221801
TBR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608
Laboratory Director: William E. Tarr, M.D. CLIA No: 31D0696246

ESPSTEIN.JEFFREY - K4666434

Page 1 - End of Report

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated. All rights reserved. 08-MPAPR. 7/31

03/28/18 08:34 #15250168 2/2

# PATIENT INFORMATION
ESPSTEIN,JEFFREY (cont.)

Quest
Diagnostics

PATIENT INFORMATION
EPSTEIN, JEFFREY

SPECIMEN INFORMATION
SPECIMEN: F7579815
REQUISITION:

REPORT STATUS FINAL

ORDERING PHYSICIAN

QUEST DIAGNOSTICS INCORPORATED
CLIENT SERVICE █████████████████

DOD: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

PHONE:

CLIENT INFORMATION

T11886
WOODSON MERRELL, M.D.
44 E 67TH STREET
NEW YORK, NY 10065

10013650

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>11:50</th></tr><tr><td>RECEIVED:</td><td>03/03/2010</td><td>21:49</td></tr><tr><td>REPORTED:</td><td>03/05/2010</td><td>10:31</td></tr></table>

<table><tr><th>Test Name</th><th>In Range</th><th>Out of</th><th>Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>CALCIUM</td><td></td><td>[x]</td><td>H</td><td>8.6-10.2 mg/dL</td><td>TBR</td></tr><tr><td>PTH, INTACT</td><td></td><td>68.9</td><td>H</td><td>10-65 pg/mL</td><td>TBR</td></tr><tr><td>Interpretive Guide</td><td>Intact</td><td>PT</td><td></td><td>Calcium</td><td></td></tr><tr><td>Normal Parathyroid Function</td><td>Normal</td><td></td><td></td><td>Normal</td><td></td></tr><tr><td>Hypoparathyroidism</td><td>Low or Low</td><td>Normal</td><td></td><td>Low</td><td></td></tr><tr><td>Primary Hyperparathyroidism</td><td>Normal</td><td>or High</td><td></td><td>High</td><td></td></tr><tr><td>Secondary Hyperparathyroidism</td><td>High</td><td></td><td></td><td>Normal or Low</td><td></td></tr><tr><td>Tertiary Hyperparathyroidism</td><td>High</td><td></td><td></td><td>High</td><td></td></tr><tr><td>Non-Parathyroid Hypercalcemia</td><td>Low or Low</td><td>Normal</td><td></td><td>High</td><td></td></tr></table>

# PATIENT INFORMATION
ESPSTEIN,JEFFREY (cont.)

## PERFORMING LABORATORY INFORMATION:

TBR *Nest Diagnostics One MalcolmAvenue Teterboro NJ 07608 Laboratory Director: William E Tarr. M.D. CLIA No: 3100696246

Page 1 - End of Report

# PATIENT INFORMATION
ESPSTEIN,JEFFREY (cont.)

## PERFORMING LABORATORY INFORMATION: (cont.)



Quest
Diagnostics

Quest Diagnostics
One Malcolm Avenue
Teterboro, New Jersey 07608-1070

QuestTrack
Intact Parathyroid Hormone

Date of Report: 03/06/2010
Patient Name: Jeffrey Epstein
Identification Number: 
Age: 57
Sex: M

T11886 10013650
WOODSON MERRELL,M.D.
44 E67th Street
New York, NY 10065

Ordering Physician:

Route: 10013650

Account Number: T11886

| Field | Value |
|---|---|
|Account Number|T11886|
|Test No.|1222A|
|Date Received|03/03/2010|
|Accession #|F7579815|

| Analyte | Result | Units | Reference Range |
|---|---:|---|---|
| Intact PTH | 68.90 | pg/mL | 10–65 pg/mL |
| Total Calcium | 10.40 | mg/dL | Female: 8.5–10.3 mg/dL; Male: 8.7–10.4 mg/dL |

| Chart axis | Label | Range |
|---|---|---|
| X-axis | Calcium (mg/dL) | 2.0–16.0 |
| Y-axis | Intact Parathyroid Hormone (pg/mL) — log scale | ~1–10,000 |

Legend (top → bottom; visual fill shown)
- Normal (empty)
- Indeterminate (light/empty)
- Secondary Hyperparathyroidism (solid black)
- Primary Hyperparathyroidism (empty)
- Hypoparathyroidism (solid black)
- Non-Parathyroid Hypercalcemia (solid black)

Note: Patient point corresponds to Calcium 10.40 mg/dL and PTH 68.90 pg/mL (slightly above the stated PTH reference range).

© 2002 Quest Diagnostics Incorporated. All rights reserved.

Quest, Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics Incorporated.

# PATIENT INFORMATION
ESPSTEIN,JEFFREY (cont.)

## PERFORMING LABORATORY INFORMATION: (cont.)

Quest
Diagnostics

# PATIENT INFORMATION
EPSTEIN, JEFFREY

QUEST DIAGNOSTICS INCORPORATED
CLIENI' SERVICE

REPORT STATUS FINAL

ORDERING PHYSICIAN

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

SPECIMEN INFORMATION
SPECIMEN: 92116012
REQUISITION:

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>08:20</th></tr><tr><td>RECEIVED:</td><td>03/03/2010</td><td>19:57</td></tr><tr><td>REPORTED:</td><td>03/08/2010</td><td>08:16</td></tr></table>

CLIENT INFORMATION

PHONE:

T11886
WOODSON MERRELL, M.D.
44 E 67TH STREET
NEW YORK, NY 10065

10013650

<table><tr><th>Test Name</th><th>In Range</th><th>Out of Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>MAGNESIUM</td><td>1.8</td><td></td><td>1.5-2.5 mg/dL</td><td>TBR</td></tr><tr><td>TSH, 3RD GENERATION</td><td>1.77</td><td></td><td>0.40-4.50 mIU/L</td><td>TBR</td></tr><tr><td>THYROID PANEL</td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>T4, TOTAL</td><td>9.4</td><td></td><td>4.5-12.5 mcg/dL</td><td></td></tr><tr><td colspan="2">Please note new reference range.</td><td></td><td></td><td></td></tr><tr><td>T3 UPTAKE</td><td>32</td><td></td><td>22-35 Percent</td><td></td></tr><tr><td>T4, FREE, CALCULATED</td><td>3.0</td><td></td><td>1.4-3.8 Units</td><td></td></tr></table>

<signature> 262

# PATIENT INFORMATION
EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

# PAT [ENT INFORMATION
EPSTEIN, JEFFREY

MEN INFORMATION

DIAGNOSTICS INCORPORATED

CIMEN: 92116012

LECTED: 03/03/2010 08:20
URTED: 03/08/2010 08:16

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

REPORT STATUS FINAL
ORDERING PHYSICIAN

<table><tr><th>CLIENT INFORMATION</th><th></th></tr><tr><td>T11886</td><td>10013650</td></tr></table>

<table><tr><th>est Name</th><th>In Range</th><th>Out of</th><th>Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>S/HDL/TIBC W FER RFX/FRUCTOSAMINE</td><td></td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>GLUCOSE, FASTING</td><td></td><td>104</td><td>H</td><td>65-99 mg/dL</td><td></td></tr><tr><td>FRUCTOSAMINE</td><td>246</td><td></td><td></td><td>190-270 umol/L</td><td></td></tr><tr><td>SODIUM</td><td>140</td><td></td><td></td><td>135-146 mmol/L</td><td></td></tr><tr><td>POTASSIUM</td><td>4.4</td><td></td><td></td><td>3.5-5.3 mmol/L</td><td></td></tr><tr><td>CHLORIDE</td><td>105</td><td></td><td></td><td>98-110 mmol/L</td><td></td></tr><tr><td>CARBON DIOXIDE</td><td>24</td><td></td><td></td><td>21-33 mmol/L</td><td></td></tr><tr><td>UREA NITROGEN</td><td>18</td><td></td><td></td><td>7-25 mg/dL</td><td></td></tr><tr><td>CREATININE</td><td>0.94</td><td></td><td></td><td>0.76-1.46 mg/dL</td><td></td></tr><tr><td>BUN/CREATININE RATIO</td><td>NOTE</td><td></td><td></td><td>6-22</td><td></td></tr><tr><td>Bun/Creatinine ratio is</td><td>not reported</td><td>when</td><td>the Bun</td><td>and</td><td></td></tr><tr><td>Creatinine values are</td><td>within normal</td><td>limits.</td><td></td><td></td><td></td></tr><tr><td>URIC ACID</td><td></td><td>[x] 8.6</td><td>H</td><td>4.0-8.0 mg/dL</td><td></td></tr><tr><td>PHOSPHORUS</td><td>3.3</td><td></td><td></td><td>2.5-4.5 mg/dL</td><td></td></tr><tr><td>CALCIUM</td><td>10.0</td><td></td><td></td><td>8.6-10.2 mg/dL</td><td></td></tr><tr><td>CHOLESTEROL, TOTAL</td><td>200</td><td></td><td></td><td>125-200 mg/dL</td><td></td></tr><tr><td>HDL CHOLESTEROL</td><td></td><td>33</td><td>L</td><td>40 mg/dL</td><td></td></tr><tr><td>CHOLESTEROL/HDL RATIO</td><td></td><td>6.1</td><td>H</td><td>2 = 5.0</td><td></td></tr><tr><td>LDL CHOL, CALCULATED</td><td><u>111</u></td><td></td><td></td><td>&lt;130 mg/dL</td><td></td></tr><tr><td>See footnote 1</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>TRIGLYCERIDES</td><td></td><td>279</td><td>H</td><td>&lt;150 mg/dL</td><td></td></tr><tr><td>PROTEIN, TOTAL</td><td>7.4</td><td></td><td></td><td>6.2-8.3 g/dL</td><td></td></tr><tr><td>ALBUMIN</td><td>4.6</td><td></td><td></td><td>3.6-5.1 g/dL</td><td></td></tr><tr><td>GLOBULIN, CALCULATED</td><td>2.8</td><td></td><td></td><td>2.1-3.7 g/dL</td><td></td></tr><tr><td>A/G RATIO</td><td>1.6</td><td></td><td></td><td>1.0-2.1</td><td></td></tr><tr><td>BILIRUBIN, TOTAL</td><td>0.7</td><td></td><td></td><td>0.2-1.2 mg/dL</td><td></td></tr><tr><td>BILIRUBIN, DIRECT</td><td>0.1</td><td></td><td></td><td>&lt;= 0.2 mg/dL</td><td></td></tr><tr><td>ALKALINE PHOSPHATASE</td><td>64</td><td></td><td></td><td>40-115 U/L</td><td></td></tr><tr><td>GGT</td><td>12</td><td></td><td></td><td>3-85 U/L</td><td></td></tr><tr><td>AST</td><td>21</td><td></td><td></td><td>10-35 U/L</td><td></td></tr><tr><td>ALT</td><td>19</td><td></td><td></td><td>9-60 U/L</td><td></td></tr><tr><td>LD</td><td>152</td><td></td><td></td><td>120-250 U/L</td><td></td></tr><tr><td>IRON, TOTAL</td><td>70</td><td></td><td></td><td>45-170 mcg/dL</td><td></td></tr><tr><td>TIBC</td><td>314</td><td></td><td></td><td>250-425 mcg/dL</td><td></td></tr><tr><td>TRANSFERRIN SATURATION</td><td>22</td><td></td><td></td><td>20-50%</td><td></td></tr></table>

Page 2 - Continued on Page 3

# PAT [ENT INFORMATION
EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

PATIENT INFORMATION

# EPSTEIN, JEFFREY

REPORT STATUS FINAL
ORDERING PHYSICIAN

QUEST DIAGNOSTICS INCORPORATED

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

CLIENT INFORMATION

SPECIMEN INFORMATION

SPECIMEN: 92116012

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>08:20</th></tr><tr><td>REPORTED:</td><td>03/08/2010</td><td>08:16</td></tr></table>

T11886 10013650

<table><tr><th>Test Name</th><th>In Range</th><th>Out of Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>CBC (INCLUDES DIFF/PLT)</td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>WBC</td><td>5.3</td><td></td><td>3.8-10.8 Thous/mcL</td><td></td></tr><tr><td>RBC</td><td>5.06</td><td></td><td>4.20-5.80 Mill/mcL</td><td></td></tr><tr><td>HEMOGLOBIN</td><td>15.0</td><td></td><td>13.2-17.1 g/dL</td><td></td></tr><tr><td>HEMATOCRIT</td><td>44.8</td><td></td><td>38.5-50.0 %</td><td></td></tr><tr><td>MCV</td><td>88.5</td><td></td><td>80.0-100.0 fL</td><td></td></tr><tr><td>MCH</td><td>29.6</td><td></td><td>27.0-33.0 pg</td><td></td></tr><tr><td>MCHC</td><td>33.4</td><td></td><td>32.0-36.0 g/dL</td><td></td></tr><tr><td>RDW</td><td>13.4</td><td></td><td>11.0 15.0 %</td><td></td></tr><tr><td>PLATELET COUNT</td><td>289</td><td></td><td>140-400 Thous/mcL</td><td></td></tr><tr><td>MPV</td><td>7.9</td><td></td><td>7.5-11.5 fL</td><td></td></tr><tr><td>TOTAL NEUTROPHILS, %</td><td>49.7</td><td></td><td>38-80%</td><td></td></tr><tr><td>TOTAL LYMPHOCYTES, &amp;</td><td>34.9</td><td></td><td>15-49%</td><td></td></tr><tr><td>MONOCYTES, %</td><td>7.5</td><td></td><td>0-13%</td><td></td></tr><tr><td>EOSINOPHILS, %</td><td>7.2</td><td></td><td>0-8%</td><td></td></tr><tr><td>BASOPHILS, %</td><td>0.7</td><td></td><td>0-2 %</td><td></td></tr><tr><td>NEUTROPHILS, ABSOLUTE</td><td>2634</td><td></td><td>1500-7800 Cells/mcL</td><td></td></tr><tr><td>LYMPHOCYTES, ABSOLUTE</td><td>1850</td><td></td><td>850-3900 Cells/mcL</td><td></td></tr><tr><td>MONOCYTES, ABSOLUTE</td><td>398</td><td></td><td>200-950 Cells/mcL</td><td></td></tr><tr><td>EOSINOPHILS, ABSOLUTE</td><td>382</td><td></td><td>15-550 Cells/mcL</td><td></td></tr><tr><td>BASOPHILS, ABSOLUTE</td><td>37</td><td></td><td>0-200 Cells/mcL</td><td></td></tr><tr><td>DIFFERENTIAL</td><td></td><td></td><td></td><td></td></tr><tr><td>An instrument</td><td>differential was</td><td>performed.</td><td></td><td></td></tr><tr><td>URINALYSIS, COMPLETE</td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>COLOR</td><td>Yellow</td><td></td><td>Yellow</td><td></td></tr><tr><td>APPEARANCE</td><td></td><td>Cloudy</td><td>Clear</td><td></td></tr><tr><td>GLUCOSE, QL</td><td>Negative</td><td></td><td>Negative mg/dL</td><td></td></tr><tr><td>BILIRUBIN, URINE</td><td>Negative</td><td></td><td>Negative</td><td></td></tr><tr><td>KETONES</td><td>Negative</td><td></td><td>Negative mg/dL</td><td></td></tr><tr><td>SPECIFIC GRAVITY</td><td>1.024</td><td></td><td>1.001-1.035</td><td></td></tr><tr><td>BLOOD www</td><td></td><td>Small (1+) *</td><td>Negative</td><td></td></tr><tr><td>PH</td><td>5.5</td><td>[ ]</td><td>5.0-8.0</td><td></td></tr><tr><td>PROTEIN, TOTAL, QL</td><td>Negative</td><td></td><td>Negative mg/dL</td><td></td></tr><tr><td>NITRITE</td><td>Negative</td><td></td><td>Negative</td><td></td></tr><tr><td>LEUKOCYTE ESTERASE</td><td>Negative</td><td></td><td>Negative</td><td></td></tr><tr><td>SQUAMOUS EPITHELIAL CELLS</td><td>None Seen</td><td></td><td>&lt;or=5 cells/hpf</td><td></td></tr><tr><td>WBC</td><td>None Seen</td><td></td><td>&lt;or=5 cells/hpf</td><td></td></tr><tr><td>BACTERIA</td><td>None Seen</td><td></td><td>None Seen/hpf</td><td></td></tr><tr><td>RBC</td><td></td><td>(4-10 H</td><td>&lt;or=3 cells/hpf</td><td></td></tr><tr><td>HYALINE CASTS</td><td>None Seen</td><td></td><td>None Seen /lpf</td><td></td></tr></table>

Page 3 - Continued on Page 4

# EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

# PATIENT INFORMATION
EPSTEIN, JEFFREY

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

QUEST DIAGNOSTICS INCORPORATED

SPECIMEN INFORMATION

SPECIMEN: 92116012

REPORTED:  03/08/2010 08:16

COLLECTED: 03/03/2010 08:20

CLIENT INFORMATION
T11886
10013650

<table><tr><th>Test Name</th><th>In Range</th><th>Out of Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>VITAMIN B12 + FOLATE</td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>VITAMIN B12, SERUM</td><td>287</td><td></td><td>200-1100 pg/mL</td><td></td></tr><tr><td colspan="5">Please note: although the reference range for Vitamin B12
is 200-1100 pg/mL, it has been reported that between 5 and
10% of patients with values between 200 and 400 pg/mL may
experience neuropsychiatric and hematologic abnormalities
due to occult B12 deficiency; less than 1% of patients with
values above 400 pg/mL will have symptoms.</td></tr><tr><td>FOLATE, SERUM</td><td>10.6</td><td></td><td>&gt; 5.4 ng/mL</td><td></td></tr><tr><td></td><td></td><td>Normal:</td><td>&gt;5.4</td><td></td></tr><tr><td></td><td></td><td>Borderline:</td><td>3.4-5.4</td><td></td></tr><tr><td></td><td></td><td>Low:</td><td>&lt;3.4</td><td></td></tr><tr><td>CARDIO CRP (R)</td><td>0.8</td><td></td><td>mg/L</td><td>TBR</td></tr><tr><td colspan="4">Low relative cardiovascular risk according to AHA/CDC
guidelines.</td><td></td></tr><tr><td>See footnote 2</td><td></td><td></td><td></td><td></td></tr><tr><td>PSA, TOTAL</td><td>0.54</td><td></td><td>&lt;=4.0 ng/mL</td><td>TBR</td></tr><tr><td>See footnote 3</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5">APOLIPOPROTEIN A-1+B TBR</td></tr><tr><td>APOLIPOPROTEIN A1</td><td>117
-</td><td></td><td>94-176 mg/dL</td><td></td></tr><tr><td>APOLIPOPROTEIN B</td><td>107</td><td></td><td>52-109 mg/dL</td><td></td></tr><tr><td>APOLIPOPROTEIN B/A1 RATIO</td><td>0.91</td><td></td><td></td><td></td></tr><tr><td>Below average risk:</td><td>&lt;0.29</td><td></td><td></td><td></td></tr><tr><td>Average risk:</td><td>0.29-1.30</td><td></td><td></td><td></td></tr><tr><td>Above average risk:</td><td>&gt;1.30</td><td></td><td></td><td></td></tr><tr><td>HEMOGLOBIN A1C
Reference Range:</td><td>Non Diabetics</td><td>(6.2) _H
&lt; 6.0%</td><td>Percent</td><td>TBR</td></tr><tr><td>HOMOCYSTEINE, CARDIO</td><td></td><td></td><td></td><td>TBR</td></tr><tr><td>_ HOMOCYSTEINE</td><td></td><td>(11.5H</td><td>&lt;11.4 MICROmol/L</td><td></td></tr></table>

# PATIENT INFORMATION
EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

PATIENT INFORMATION
EPSTEIN, JEFFREY

REPORT STATUS: FINAL
ORDERING PHYSICIAN

QUEST DIAGNOSTICS INCORPORATED

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

SPECIMEN INFORMATION

<table><tr><th>Test Name</th><th></th><th></th><th>In Range</th><th></th><th>Out of Range</th><th>Reference Rang.</th><th>Lab</th></tr><tr><td>VITAMIN</td><td>D,25-0H,LC/MS/MS</td><td></td><td></td><td></td><td></td><td></td><td>TBR </td></tr><tr><td>VITAMIN D,</td><td>25-0H, TOTAL</td><td></td><td>42</td><td></td><td></td><td>20-100 ng/mL</td><td></td></tr><tr><td>VITAMIN D,</td><td>25-OH, D3</td><td></td><td>42</td><td></td><td></td><td>ng/mL</td><td></td></tr><tr><td>VITAMIN D,</td><td>25-OH, D2</td><td></td><td>&lt;4</td><td></td><td></td><td>ng/mL</td><td></td></tr><tr><td colspan="7">25-OHD3 indicates both endogenous production and
supplementation. 25-OHD2 is an indicator of exogenous sources
such as diet or supplementation. Therapy is based on
measurement of Total 25-OHD, with levels &lt;20 ng/mL indicative
of Vitamin D deficiency, while levels between 20 ng/mL and
30 ng/mL suggest insufficiency. Optimal levels are &gt;30 ng/mL.</td><td></td></tr><tr><td>MAGNESIUM,RBC</td><td></td><td></td><td>4.6</td><td></td><td></td><td>4.0-6.4 mg/dL</td><td>AMD</td></tr><tr><td colspan="3">FOOTNOTE(S): </td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1 </td><td>Desirable range is
heart disease (CHD)
patients with known</td><td>&lt;100
or
CHD.</td><td>mg/dL
diabetes,</td><td>for
and</td><td>patients with
&lt;70 mg/dL for</td><td>coronary
diabetic</td><td></td></tr><tr><td>2</td><td>For Ages &gt;17 Years:</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>CCRP mg/L</td><td>Risk</td><td>according</td><td></td><td>to AHA/CDC</td><td>guidelines</td><td></td></tr><tr><td></td><td>&lt;1.0</td><td>Low</td><td>cardiovascular</td><td></td><td>risk</td><td></td><td></td></tr><tr><td></td><td>1.0 - 3.0</td><td></td><td>Average</td><td></td><td>cardiovascular risk</td><td></td><td></td></tr><tr><td></td><td>3.1 - 10.0</td><td>High</td><td>cardiovascular</td><td></td><td>risk</td><td></td><td></td></tr><tr><td></td><td>&gt;10.0</td><td></td><td>Persistent
non-cardiovascular</td><td></td><td>elevations may
inflammation</td><td>represent</td><td></td></tr><tr><td>3 </td><td>This test was performed
chemiluminescent
assay methods cannot
regardless of value,
evidence of the</td><td>method.
be

presence</td><td>using
Values
used
should not
or</td><td>the

be
absence</td><td>Siemens (Bayer)
obtained from
interchangeably. PSA
interpreted as
of disease.</td><td>different
levels,
absolute</td><td></td></tr><tr><td colspan="8">PERFORMING LABORATORY INFORMATION:</td></tr><tr><td>AMD  Quest
Laboratory</td><td>Dtagnostics Nichpls Chanc,lly
Director: Kenneth Risco,</td><td>14225
MD,PhD</td><td>NewbrOOK
CLIA No:</td><td>Drive
49D0221801</td><td>Chantilly VA 20151</td><td></td><td></td></tr><tr><td>113R Quest
CLIA No:</td><td>Diagnostics One Malcolm Avenue
3100696246</td><td>Teterboro</td><td>NJ 07608</td><td></td><td>LaboratoryDirector:</td><td>William E. Tarr. M.D.</td><td></td></tr></table>

SPECIMEN: 92116012

COLLECTED: 03/03/2010 08:20

CLIENT INFORMATION

T11886 10013650

REPORTED: 03/08/2010 08:16

EPSTEIN,JEFFREY - 92116012

Page 5 - End of Report

# PATIENT INFORMATION
EPSTEIN, JEFFREY (cont.)

Quest
Diagnostics

PATIENT INFORMATION
EPSTEIN, JEFFREY

SPECIMEN INFORMATION
SPECIMEN: F7579848
REQUISITION:

REPORT STATUS FINAL

ORDERING PHYSICIAN

QUEST DIAGNCSTIcS INCORPORATED
CLIENT SERVICE

DOB: 01/20/1953 AGE: 57
GENDER: M FASTING: Y

PHONE:

CLIENT INFORMATION

10013650

T11886
WOODSON MERRELL, M.D.
44 E 67TH STREET
NEW YORK, NY 10065

<table><tr><th>COLLECTED:</th><th>03/03/2010</th><th>08:20</th></tr><tr><td>RECEIVED:</td><td>03/03/2010</td><td>21:52</td></tr><tr><td>REPORTED:</td><td>03/08/2010</td><td>08:16</td></tr></table>

<table><tr><th>Test Name</th><th>In Range</th><th>Out</th><th>of</th><th>Range</th><th>Reference Range</th><th>Lab</th></tr><tr><td>INSULIN,FREE</td><td>7.8</td><td></td><td></td><td></td><td>1.5-14.9 uIU/mL</td><td>QNI</td></tr></table>

Insulin levels vary widely in specimens taken from non-fasting individuals.

# PATIENT INFORMATION
EPSTEIN, JEFFREY (cont.)

## PERFORMING LABORATORY INFORMATION:

QNI Quest Oiagnostics. Nichols Institute 2760E Ortega Highway San Juan Capistrano CA 92690 LabOratOry Director: Dr. Jon N. Nekamoto CLIA No: 050643152